Inclusion Criteria : 
  -  Participants were eligible for inclusion in the study if they had evidence suggesting acute ischemic stroke that lasted for â‰¤ 4.5 hours  . 
  -  Those Participants were treated with intravenous thrombolytic therapy (  ( recombinant tissue plasminogen activator ( rt - PA )  )  . 
Exclusion Criteria : 
  -  Those who had hemorrhagic stroke
  -  participants presented with acute myocardial infarction , cerebrovascular stroke in the previous three months . 
  -  serious head trauma in the previous three months . 
  -  urinary tract , lung , or gastrointestinal hemorrhage within the three weeks . 
  -  serious trauma or major surgery within the previous two weeks . 
  -  lumbar or arterial puncture at a non - compressible site within one week . 
  -  those received heparin within 48 hours , resulting in an activated partial thromboplastin time greater than the upper limit of normal . 
  -  systolic pressure > 185 mmHg or diastolic pressure > 110 mmHg . 
  -  blood glucose < 50 or > 400 mg / dL . 
  -  current use of anticoagulants with an International Normalized Ratio > 1.7 or prothrombin time > 15 sec; platelet count < 100 , 000 / mm3. 
  -  pregnancy; serious heart , lung , kidney or other organ dysfunction . 
  -  allergy to active ingredients of rt - PA; patients with > 4.5 hours from the last time known to be asymptomatic . 
  -  those in whom troponin was not measured at admission were excluded from the study